Advanced Flower Capital (AFCG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for May 19, 2025, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of Robert Levy as director is up for shareholder vote, with board recommending approval.
Ratification of CohnReznick LLP as independent registered public accounting firm for 2025 is proposed, with board recommending approval.
Board of directors and corporate governance
Board recommends voting in favor of both the director nominee and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Advanced Flower Capital
- Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 202510 Mar 2026 - BDC conversion expanded investment scope; $31.3M interest income, $0.05 dividend declared.AFCGQ4 20254 Mar 2026
- Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCGQ2 20242 Feb 2026
- Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCGQ3 202414 Jan 2026
- Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCGQ4 202424 Dec 2025
- REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCGRegistration Filing16 Dec 2025
- Shareholders will vote on director election and auditor ratification, with Board support.AFCGProxy Filing2 Dec 2025
- Shareholders to vote on REIT-to-BDC conversion, new advisory agreement, and leverage increase.AFCGProxy Filing2 Dec 2025
- Shareholders to vote on REIT-to-BDC conversion and new advisory agreement for expanded flexibility.AFCGProxy Filing2 Dec 2025